AI brief of an SEC Form 8-K · Humana (HUM)

Humana cuts GAAP EPS guidance to at least $6.52; Q2 adjusted EPS rises to $7.61

Mixed Impact 4 of 5 guidance Written later

Humana reported second-quarter 2026 GAAP EPS of $5.73, up from $4.51 a year earlier, and adjusted EPS of $7.61, up from $6.27, on revenue of $40.9 billion versus $32.4 billion. The company lowered its full-year 2026 GAAP EPS guidance to at least $6.52 from at least $8.36, while affirming adjusted EPS guidance of at least $9.00, which it says reflects a year-over-year decline tied to the Star Ratings headwind.

Key points

  • Second-quarter 2026 GAAP EPS was $5.73 versus $4.51 in 2Q25; adjusted EPS was $7.61 versus $6.27.
  • Revenue was $40,867 million in 2Q26 versus $32,388 million in 2Q25; GAAP pretax results were $952 million versus $741 million.
  • FY 2026 GAAP EPS guidance was revised to at least $6.52 from at least $8.36; adjusted EPS guidance of at least $9.00 was affirmed.
  • Insurance segment GAAP benefit ratio was 91.2 percent in 2Q26, in line with management's guidance of slightly above 91 percent.

The filing

CompanyHumana (HUM)
Form8-K, current report
Filed with the SECJul 29, 2026, 6:19 AM ET
Accession number0000049071-26-000045

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.